ABLDABL Diagnostics Société anonyme
3.620EURMkt Cap: 58.17M EURP/E: 60.33Last update: 2026-05-21

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and intern…

loading…
Indicators:|

Key Statistics

Company
Market Cap58.17M EUR
Enterprise Value60.10M EUR
Revenue (TTM)6.23M EUR
Gross Profit6.62M EUR
Net Income (TTM)986.70K EUR
Revenue/Share0.4120 EUR
Last Price3.620 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees19
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR001400AHX6
Valuation
P/E (Trailing)60.33
P/E (Forward)
PEG1.94
EV/EBITDA372.42
EV/Revenue9.65
P/S9.34
P/B7.78
EPS (TTM)0.06
EPS (Forward)
52W Range
3.50040% of range3.800
52W High3.800 EUR
52W Low3.500 EUR
Profitability
Gross Margin95.29%
Oper. Margin-2.00%
EBITDA Margin2.59%
Profit Margin14.20%
ROE12.93%
ROA7.62%
Growth
Revenue Growth12.40%
Earnings Growth
Cash Flow & Leverage
Operating CF1.51M EUR
CapEx (TTM)792.67K EUR
FCF Margin
FCF Yield
Net Debt1.77M EUR
Net Debt/EBITDA10.94
Balance Sheet
Debt/Equity0.29
Current Ratio4.00
Quick Ratio3.54
Book Value/Sh0.4650 EUR
Cash/Share0.0570 EUR
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.0500 EUR
Div. Yield2.91%
5Y Avg Yield
Payout Ratio81.43%
Ex-Div DateJul 3, 2026
Pay Date
Splits
Last Split8:1
Split DateMay 18, 2022
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.16.07M
Float121.50K
Insiders97.25%
Institutions0.00%
Technical
SMA 502.938 (+23.2%)
SMA 2003.589 (+0.9%)
Beta-0.62
S&P 52W Chg27.23%
Avg Vol (30d)16.63K
Avg Vol (10d)33.98K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)